Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 15, No 1 (2022) The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015–2020 Abstract  similar documents
I. K. Petrukhina, P. A. Lebedev, E. P. Gladunova, T. K. Ryazanova, A. A. Garanin, P. R. Blinkova
 
Vol 14, No 1 (2021) History of controlled trials in medicine: real priorities are little-known. Report 1. Basic concepts, terms, and disciplines that use medical experiment: historical and philosophical sources Abstract  similar documents
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov
 
Vol 14, No 3 (2021) History of controlled trials in medicine: real priorities are little-known. Report 2. From early experiments to the present day: without alternation and randomization Abstract  similar documents
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov
"... on the history of CT is J.P. Bull’s dissertation (1951). The formed database as of July 2020 contained more than ..."
 
Vol 14, No 4 (2021) History of controlled trials in medicine: real priorities are little-known. Report 3. Quasi-randomized and randomized trials in humans and animals Abstract  similar documents
A. N. Koterov, O. A. Tikhonova, L. N. Ushenkova, A. P. Biryukov
"... according to the table of random numbers, was J.A. Bell, 1941 (USA). Often referred to as the ‘new era in CT ..."
 
Vol 13, No 4 (2020) Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia Abstract  similar documents
V. G. Deriushkin, A. P. Ternavskii, S. V. Gatsura
 
Vol 14, No 2 (2021) Impact of disease information (Ebola and COVID-19) on the pharmaceutical sector in Russia and USA Abstract  similar documents
E. A. Fedorova, D. O. Afanasyev, A. V. Sokolov, M. P. Lazarev
 
Vol 14, No 3 (2021) Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer Abstract  similar documents
O. P. Bobrova, S. K. Zyryanov, N. A. Shnayder, M. M. Petrova
 
Vol 16, No 2 (2023) Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy Abstract  similar documents
M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina
 
Vol 16, No 1 (2023) Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program Abstract  similar documents
T. O. Bessonova, P. A. Mukhortova, R. A. Teryan, A. D. Bagdasarov, N. Z. Musina
 
Vol 16, No 4 (2023) Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market Abstract  similar documents
I. K. Petrukhina, T. K. Ryazanova, E. P. Gladunova, A. M. Lazarev, A. A. Krivova
"... B Antimetabolites, L02A Hormones and related compounds and L02B Hormone antagonists and related ..."
 
Vol 16, No 4 (2023) Pharmacoeconomic study of fluorescent lymphography and radionuclide diagnostics methods for sentinel lymph node detection in breast cancer Abstract  similar documents
E. P. Kulikov, M. V. Shomova, D. S. Titov, A. N. Demko, M. A. Maistrenko
"... significantly lower than the median CERRD values by average of 43.29% (p<0.001): from 40.36% (p<0.001) to 44 ..."
 
Online First Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease Abstract  similar documents
E. A. Orlova, V. I. Petrov, I. P. Dorfman, O. V. Shatalova, M. A. Orlov
 
Vol 14, No 3 (2021) Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines Abstract  similar documents
I. K. Petrukhina, R. I. Yagudina, N. V. Veyner, T. K. Ryazanova, E. P. Gladunova, V. A. Kurkin, P. R. Blinkova, E. N. Zaitseva
 
Online First Chemoreactomic analysis of acyzole in comparison with zinc derivatives of non-steroidal anti-inflammatory drugs Abstract  similar documents
P. A. Galenko-Yaroshevsky, I. Yu. Torshin, A. N. Gromov, O. A. Gromova, R. A. Murashko, A. V. Zelenskaya, L. O. Alukhanyan, O. V. Shelemekh
 
Vol 13, No 3 (2020) The review of the foreign experience on the financing of innovative medical technologies Abstract  similar documents
V. V. Omelyanovskiy, I. A. Zheleznyakova, T. P. Bezdenezhnykh, M. L. Lazareva, D. V. Fedyaev
 
Vol 16, No 2 (2023) Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance Abstract  similar documents
N. Yu. Nikolenko, D. A. Kudlay, S. E. Borisov, T. E. Sannikova, N. P. Doktorova
 
Vol 16, No 2 (2023) Real-world data: principles of use in decision making and in health technology assessment Abstract  similar documents
V. V. Omelyanovskiy, F. V. Gorkavenko, N. V. Ignatyeva, P. A. Mukhortova, O. R. Ryzhova, T. S. Teptsova, A. A. Kingshott, B. B. Kondratyeva
 
Vol 16, No 1 (2023) Efficiency of Levilimab in patients with moderate and severe COVID-19 Abstract  similar documents
Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A.  S. Kolbin, M. V. Livshits, T.  A. Usmanova, A. M. Fakhrutdinova, Yu. S.  Konstantinova, A. P. Gubanov
"... % confidence interval (CI) 1.19–2.47; p<0.01) and for the severe course of COVID-19 (63% and 82%, respectively ..."
 
Vol 13, No 2 (2020) Analysis of 19.9 million publications from the PubMed/MEDLINE database using artificial intelligence methods: approaches to the generalizations of accumulated data and the phenomenon of “fake news Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, N. P. Vanchakova, A. N. Galustyan, Zh. D. Kobalava, T. R. Grishina, A. N. Gromov, I. A. Ilovaiskaya, V. M. Kodentsova, A. G. Kalacheva, O. A. Limanova, V. A. Maksimov, S. I. Malyavskaya, E. V. Mozgovaya, N. I. Tapilskaya, K. V. Rudakov, V. A. Semenov
 
Vol 14, No 2 (2021) Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis Abstract  similar documents
N. Yu. Nikolenko, D. А. Kudlay, N. P. Doktorova
 
Vol 15, No 4 (2022) Concentration of vitamin D metabolite – 25(OH)D3 as a predictor of breast cancer progression Abstract  similar documents
D. Е. Frolova, N. P. Lapochkina, О. А. Gromova, I. Yu. Torshin
 
Vol 14, No 1 (2021) Review of foreign experience in the implementation of eHealth Abstract  similar documents
P. V. Minaev, D. V. Fedyaev, Yu. V. Seryapina, T. V. Skomorokhova
 
Vol 12, No 1 (2019) Individual cost accounting in the management of medical organizations Abstract  similar documents
I. A. Zheleznyakova, L. A. Kovaleva, T. A. Khelisupali
 
Vol 12, No 1 (2019) Effective search for potentially innovative scientific results in medicine Abstract  similar documents
M. B. Khrustalev, A. A. Maksimova
 
Vol 15, No 4 (2022) Analysis of the main indicative values of the pharmaceutical market retail sectors in the constituent entities of the Russian Federation Abstract  similar documents
I. К. Petrukhina, Т. К. Ryazanova, А. I. Khusainova, А. V. Egorova, P. R. Blinkova
 
Vol 14, No 4 (2021) Features of intellectual property protection mechanisms on the example of orphan drugs circulation Abstract  similar documents
D. S. Yurochkin, К. V. Nasonova, Z. М. Golant, I. А. Narkevich, V. P. Trukhin
 
Vol 12, No 1 (2019) Prevalence survey of musculoskeletal and connective tissue disorders in the Russian Federation Abstract  similar documents
T. A. Oleynikova, D. N. Pozhidaeva, A. Yu. Oreshko
 
Vol 14, No 4 (2021) Machine learning based on laboratory data for disease prediction Abstract  similar documents
A. V. Gusev, R. E. Novitskiy, A. A. Ivshin, A. A. Alekseev
 
Vol 15, No 4 (2022) Historical milestones of the invention and use of placebo Abstract  similar documents
A. N. Koterov
"... терапевтического, так и экспериментального плацебо. В первом случае пионерами должны быть названы A. Sutherland ..."
 
Vol 14, No 4 (2021) Application of medical products: mandatory requirements, supervision of their compliance Abstract  similar documents
O. A. Makhova
 
Vol 16, No 4 (2023) DMOADs and DMARDs in the treatment of patients with joint and spine diseases Abstract  PDF (Eng)  similar documents
O. A. Shavlovskaya
 
Vol 14, No 2 (2021) Survey-based evaluation of the awareness of pharmaceutical specialists on the pharmacotherapy of climacteric syndrome Abstract  similar documents
M. A. Chernyavskaya, I. A. Narkevich
 
Vol 13, No 2 (2020) Biological effects of phytoestrogens: clinical effectiveness and potential application in the treatment of climacteric syndrome Abstract  similar documents
M. A. Chernyavskaya, I. A. Narkevich
 
Vol 16, No 4 (2023) Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C Abstract  similar documents
I. A. Narkevich, E. A. Tsitlionok
 
Vol 15, No 1 (2022) The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies Abstract  similar documents
A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem
 
Vol 15, No 2 (2022) Clinical study of real-time polymerase chain reaction test kit for SARS-CoV-2 ribonucleic acids detection Abstract  similar documents
M. Yu. Dmitryukova, A. A. Golod, M. E. Senina, A. E. Gushchin
 
Vol 14, No 2 (2021) Effect of vitamin D intake on quality of life parameters in office workers Abstract  similar documents
A. T. Sharman, Sh. K. Adambekov, A. A. Imandosova, G. F. Elemesova
"... .e. its insufficiency occurs, and <20 ng/ml – as vitamin D deficiency (p<0.0001). The SF-36 score showed ..."
 
Vol 13, No 2 (2020) Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union Abstract  similar documents
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich
 
Vol 13, No 3 (2020) Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, A. V. Naumov, V. A. Maksimov
 
Vol 15, No 1 (2022) Study of methods for state regulation of prices and costs of the health care system for medicines in the United Kingdom Abstract  similar documents
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich
 
Vol 14, No 4 (2021) Economic burden of chronic viral hepatitis C Abstract  similar documents
R. A. Yakhina, I. A. Lakman, D. A. Valishin, R. Kh. Bakhitova
 
Vol 16, No 3 (2023) Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia Abstract  similar documents
A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva
 
Online First Chemo-рroteomic analysis of the pharmacological properties of vitamin В12 derivatives Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, I. A. Dereven’kov, L. A. Maiorova
 
Vol 12, No 1 (2019) The use of the level of evidence and grade of recommendations scales in developing clinical guidelines in the Russian Federation Abstract  similar documents
N. I. Zhuravleva, L. C. Shubina, O. A. Sukhorukikh
 
Vol 15, No 3 (2022) Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome) Abstract  similar documents
I. Yu. Torshin, О. A. Gromova, A. M. Lila
"... of obesity. By inhibiting O-glucosamination of intranuclear proteins (i.e., p53), GS can accelerate lipolysis ..."
 
Vol 16, No 1 (2023) Systematic computer analysis of the pharmacology of bioflavonoids in the context of increasing the body's antiviral defenses Abstract  similar documents
O. A. Gromova, I. Yu. Torshin, A. G. Chuchalin
 
Vol 14, No 2 (2021) Systematic computer analysis of published literature on nutritional support for vaccination Abstract  similar documents
A. G. Chuchalin, I. Yu. Torshin, O. A. Gromova
 
Vol 13, No 2 (2020) Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis? Abstract  similar documents
A. M. Lila, I. Yu. Torshin, O. A. Gromova
"... биологические эффекты фактора некроза опухолей-a (ФНО-a). Избыточная активность NF-kB также стимулирует и ..."
 
Vol 13, No 4 (2020) Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm Abstract  similar documents
M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov
 
Vol 14, No 4 (2021) Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate Abstract  similar documents
I. Yu. Torshin, A. M. Lila, O. A. Gromova
 
1 - 50 of 146 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)